LAMOGINE 25 MG

Country: Իսրայել

language: անգլերեն

source: Ministry of Health

active_ingredient:

LAMOTRIGINE

MAH:

TRIMA ISRAEL PHARMACEUTICAL PRODUCTS MAABAROT LTD

ATC_code:

N03AX09

pharmaceutical_form:

TABLETS

composition:

LAMOTRIGINE 25 MG

administration_route:

PER OS

prescription_type:

Required

manufactured_by:

TRIMA ISRAEL PHARMACEUTICAL PRODUCTS MAABAROT LTD, ISRAEL

therapeutic_group:

LAMOTRIGINE

therapeutic_area:

LAMOTRIGINE

therapeutic_indication:

EpilepsyAdults and adolescents aged 13 years and above- Adjunctive or monotherapy treatment of partial seizures and generalised seizures, including tonic-clonic seizures.- Seizures associated with Lennox-Gastaut syndrome. Lamogine is given as adjunctive therapy but may be the initial antiepileptic drug (AED) to start with in Lennox- Gastaut syndrome.Children and adolescents aged 2 to 12 years- Adjunctive treatment of partial seizures and generalised seizures, including tonic- clonic seizures and the seizures associated with Lennox-Gastaut syndrome.- Monotherapy of typical absence seizures.Bipolar disorderAdults aged 18 years and above- Prevention of depressive episodes in patients with bipolar I disorder who experience predominantly depressive episodes.Lamogine is not indicated for the acute treatment of manic or depressive episodes.

authorization_date:

2021-10-31

PIL

PATIENT LEAFLET IN ACCORDANCE WITH THE PHARMACISTS’
REGULATIONS (PREPARATIONS) – 1986
The medicine is dispensed according to a physician’s prescription
only
LAMOGINE 25 MG, 50 MG, 100 MG, 200 MG TABLETS
Each tablet contains: 25 mg, 50 mg, 100 mg, 200 mg lamotrigine.
Inactive ingredients and allergens in this medicine: See section 6
‘Additional information’ and section 2 under ‘Important
information
about some of this medicine’s ingredients’.
READ THE ENTIRE LEAFLET CAREFULLY BEFORE USING THE MEDICINE. This
leaflet contains concise information about the medicine. If you have
any further questions, refer to the physician or the pharmacist.
This medicine has been prescribed for you. Do not pass it on to
others. It may harm them even if it seems to you that their medical
condition is similar.
1. WHAT IS THE MEDICINE INTENDED FOR?
LAMOGINE IS INTENDED FOR THE TREATMENT OF EPILEPSY
In adults and adolescents aged 13 years and above:
Lamogine is given as monotherapy or in combination with other
medicines to treat partial seizures and generalized seizures,
including
tonic-clonic seizures.
Seizures that occur with Lennox-Gastaut syndrome. Lamogine is
given as combination therapy with other medicines but may be
used as the initial antiepileptic medicine when starting treatment of
Lennox-Gastaut syndrome.
In children and adolescents aged 2 to 12 years:
Lamogine is given as combination therapy with other medicines to
treat partial seizures and generalized seizures, including
tonic-clonic
seizures and seizures occurring with Lennox-Gastaut syndrome.
Lamogine is given as monotherapy in typical absence seizures.
LAMOGINE IS INTENDED FOR TREATMENT OF BIPOLAR DISORDER
In adults aged 18 years and above:
Lamogine is given to prevent depressive episodes in patients with
bipolar disorder who experience predominantly depressive episodes.
Lamogine is not intended for immediate (acute) treatment of manic
or depressive episodes.
THERAPEUTIC GROUP:
Lamogine belongs to a group of medicines called anticonvulsants.
Lamogine bl